StockWatch
·
ICICI LOMBARD GENERAL INSURANCE COMPANY LTD · QQ2 FY-2027 · THE CALL

Solid growth masked by Motor headwinds; FY27 hinges on rate hikes

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsICICIGIICICI Lombard General Insurance Company Ltd19 Oct 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade B

Management met H1 delivered numbers. Guided Motor loss ratio 65-67% was maintained. Q1 TP provision (₹1.65 Cr) deemed sufficient; no incremental provision called in Q2.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Solid topline growth (+19.3% YoY) and market-leading underwriting discipline in Motor (108.3% CR vs industry 131.4%) offset by Motor TP headwinds and elevated CAT losses reducing near-term visibility. Health (26.8% growth) and digital initiatives offer medium-term tailwinds, but Motor TP rate hikes remain uncertain; FY27 earnings dependent on regulatory outcomes.

₹7812.7 Cr

Revenue · +19.3% YoY

₹946.4 Cr

Reported PAT · +15.5% YoY

Compressing

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Motor segment growth 13.0% in H1, maintaining market leadership

MET

Delivered H1 FY27 shows Motor 13.0% vs industry 13.1%, market share 10.3%

Motor combined ratio 108.3% in Q1 vs industry 131.4% shows discipline

MET

ICICI's Motor CR narrowed gap to industry to 23.1 percentage points from 17.4 ppts Q1 FY26

Health segment growth 26.8% for H1 FY2027, well ahead of industry 21%

MET

Delivered shows Health growing significantly; Retail Health 66.4%, Group Health 15.4%

Revenue growth 19.3% YoY reflects broad-based momentum

MET

Delivered result: ₹7812.7 Cr, +19.3% YoY. Growth driven by all segments but Motor TP pressure headwind.

Supreme Court Motor TP judgement impact adequately provisioned for in Q1

MET

₹1.65 Cr provision in Q1; Q2 Motor TP loss ratio impact baked into 108.3% CR; no further incremental needed

CAT losses in Q2 ~118 crores offset by improved underwriting elsewhere

MISS

Gopal cited ~118 Cr total CAT impact in Q2 vs ~74-75 Cr in Q2 FY26; flood-driven; OR would trend better

Earnings quality

What changed since the last call

Deltas vs. the prior call

Motor TP loss ratio impact now baked in

Neutral

Q1 FY27 ₹1.65 Cr provision for TP adjustment was prudent. Q2 Motor CR 108.3% reflects integrated view; no further incremental provision signalled. Management reiterating TP loss ratio 65-67% range as normal going forward.

Commercial lines recovery underway

Upgrade

Q1 had ~118 Cr exceptional loss (large one-off accounts over 9 years). Q2 showed moderation; management pivoting to retention focus (+3-5% uplift). Segment trajectory improving.

Health growth maintained strong

Neutral

Retail Health 66.4% growth H1 (vs 32% industry), market share 4.7% (from 3.7% prior year). Sustained 2x outperformance relative to industry 21% growth in Health. Momentum intact vs Q1 FY27 call.

Distribution reforms framed as positive long-term

Upgrade

IRDA consultation paper on recalibrating insurance distribution seen as market re-boot, not headwind. Management sees penetration gains via lower-cost digital channels and improved accessibility post-reform implementation (FY27-28).

The Q&A

Analysts pressed hard on Motor TP (basis points deterioration, rate hike risk, CV mix impact) and CAT volatility. Management held position on disciplined underwriting discipline, citing Motor CR gap vs industry (23.1 ppts) as proof of pricing power. On distribution reforms, management acknowledged uncertainty but framed as structural opportunity. Tone was confident, not evasive; no guidance withdrawn, metrics reaffirmed.

The exchanges that mattered

Motor TP loss ratio — Nischint Chawathe, Kotak

Partial

TP is long-tail liability. Q1 ₹1.65 Cr provision reflects prudent reserving on judgment. No incremental provision needed; Q2 impact baked in as business-as-usual. Range 65-67% maintained; development over quarters will play out naturally.

Motor OD loss ratio — Sanket Godha, Avendus Spark

Answered

Q2 had ~118 Cr CAT impact (flood events, severe weather); adjusted for CAT, OD loss ratio would be materially better and sequentially improving. Business-as-usual TP range stable; CAT-adjusted trajectory positive.

Distribution reforms impact — Nidhesh, Investec

Answered

Landmark reform; recalibration of distribution will result in improved penetration, accessibility, and cost efficiency. Motor renewals showing +3-5% increase in retention rates already visible. Reforms are positive long-term for market and ICICI well-positioned given digital reach.

EV impact on Motor loss ratios — Sanjet Godha

Answered

EV penetration in ICICI Motor book is 7-8% (vs 9.7% in market). EV TP loss ratios elevated; OD loss ratios even higher than non-EV. But contribution is single-digit and will grow over time. Long-distance EV still restricted; difference vs non-EV is margin not systemic.

Health growth trajectory — Swarnabh Mukherjee, 360 OneCapital

Answered

Earned premium growth intact and strong. Retail Health 66.4% outpaces industry 32%; Group Health 15.4%. Commercial Health growth was impacted by Crop underwriting caution; exclude Crop and all businesses show strong momentum. Growth in Health earned premium trajectory continues.

Expense management and EOM limits — Avinash Singh, Emkay Global

Answered

ICICI Lombard has always maintained EOM within 30% on annual basis. Given business mix and competitive intensity, some quarters may see temporary pressure; but annual compliance maintained consistently. Regulatory scrutiny on peers exceeding 30% creates opportunity for ICICI discipline.

Guidance

Forward guidance and management's confidence

Motor loss ratio range 65-67% (maintained, no change)

High

Reiterated at call; TP reserve baked in Q1; no further incremental provisions required; range reflects normalized Motor portfolio

Digital sourcing to scale 6% to 15% (medium-term roadmap)

Medium

Strategic priority articulated; IL TakeCare + WhatsApp Gen-AI bot enabling 40% of new business; ramp driven by channel economics

Expense of management to stay within 30% (regulatory compliance)

High

ICICI Lombard has consistently maintained <30% EOM on annual basis; regulatory limit; competitive advantage vs peers

Risks the call surfaced

Ranked by how much they should concern a holder

Motor TP economics

High

Supreme Court Shishupal judgement (TP reserve adequacy) is ongoing; final premium rate guidance not finalised. If rates cut (deflation scenario), Motor margin at risk.

CAT volatility

Medium

Q2 CAT losses (~118 Cr) materially above prior-year ~₹74-75 Cr. Flood-driven (monsoon risk). Adjusted combined ratio would be >10 ppts better; unhedged tail-risk.

Motor competitive intensity

Medium

Industry Motor combined ratio deteriorated to 131.4% in Q1 FY27 from 125% in Q1 FY26. Fierce competition on renewal; ICICI's CR advantage (108.3%) may narrow if competitors match pricing.

Health profitability

Low

Health loss ratio in Q2: Group Health 97.9% vs Q2 FY26 93.7% (deterioration); Retail Health 64.6% vs Q2 FY26 65.4% (improvement). Mixed signal; Group Health margin tightening.

Regulatory/distribution reforms

Medium

IRDA distribution consultation paper seeking to overhaul insurance distribution (commission caps, transparency, direct digital channels). Positive long-term (penetration, affordability) but near-term execution risk and margin uncertainty.

Management

Score 8/10. Clear, transparent. Specifics on Motor TP, CAT impacts, Health growth drivers provided. Management owns Motor headwinds candidly; no spin. H1 results delivered against expectations: +19.3% revenue, +15.5% PAT. Motor loss ratio range (65-67%) maintained despite adverse environment. Digital rollout on track (23.3M app downloads).

What to watch next
  • 1 · Oct-Nov 2026

    Motor TP premium rate guidance finalised by regulator

  • 2 · Q3 FY27

    Festive season Motor sales surge; volume growth test for sustainability

  • 3 · FY27-28

    Distribution reforms rollout; penetration gains in Health and Motor renewal

Health (26.8% growth) and digital initiatives offer medium-term tailwinds, but Motor TP rate hikes remain uncertain; FY27 earnings dependent on regulatory outcomes.

Informational and educational content only. Not investment advice.